← Back to Patent Explorer
US5157049A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of treating cancers sensitive to treatment with water soluble derivatives of taxol

Assignee: United States Department of Health and Human Services
•
Filing: 1991-10-31
•
Granted: 1992-10-20
•
Expires: 2011-10-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention involves the treatment of cancer in humans by administering water soluble derivatives of taxol. The types of cancer so treatable are those sensitive to treatment with taxol.

Inventors

  • 👤 Rudiger D. Haugwitz
  • 👤 Leon Zalkow
  • 👤 Jan Glinski
  • 👤 Mathew Suffness
  • 👤 Howard M. Deutsch
  • 👤 Venkatachala Narayanan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 08:55
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/335; A61K31/40; A61K31/435; A61K31/44; A61K31/445; A61K31/535; A61K31/54; C; C07; C07D; C07D305/00; C07D305/14

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 211 words
A method of treating cancer sensitive to treatment with the compound set forth below, comprising administering to a subject afflicted with said cancer, an effective amount of the water soluble derivative of the compound of the following formula to cause regression of said cancer: ##STR4## Wherein: Z=ethylene, propylene, CHCH, 1,2-cyclohexane, 1,2-phenylene, R 1 =OH base, NR 2 R 3 , OR 3 , SR 3 , OCH 2 CONR 4 R 5 , OH R 2 =hydrogen, methyl R 3 =(CH 2 ) n NR 6 R 7 ; (CH 2 ) n NR.sup.⊕6 R 7 R 8 X.sup.⊖ n=1 to 3 R 4 =hydrogen, lower alkyl containing 1 to 4 carbons R 5 =hydrogen, lower alkyl containing 1 to 4 carbons, benzyl, hydroxyethyl, CH 2 CO 2 H, dimethylaminoethyl R 6 R 7 =lower alkyl containing 1 or 2 carbons, benzyl or R 6 and R 7 together with the nitrogen atom of NR 6 R 7 form the following rings ##STR5## R 8 =lower alkyl containing 1 or 2 carbons, benzyl X.sup.⊖ =halide base=NH 3 , (HOC 2 H 4 ) 3 N, N(CH 3 ) 3 , CH 3 N(C 2 H 4 OH) 2 , NH 2 (CH 2 ) 6 NH 2 , N-methylglucamine, NaOH, KOH.
Claim 2
Independent Claim 211 words
A method of treating cancer sensitive to treatment with the compound set forth below, comprising administering to a subject afflicted with said cancer, an effective amount of the water soluble derivative of the compound of the following formula to cause regression of said cancer: ##STR4## Wherein: Z=ethylene, propylene, CHCH, 1,2-cyclohexane, 1,2-phenylene, R 1 =OH base, NR 2 R 3 , OR 3 , SR 3 , OCH 2 CONR 4 R 5 , OH R 2 =hydrogen, methyl R 3 =(CH 2 ) n NR 6 R 7 ; (CH 2 ) n NR.sup.⊕6 R 7 R 8 X.sup.⊖ n=1 to 3 R 4 =hydrogen, lower alkyl containing 1 to 4 carbons R 5 =hydrogen, lower alkyl containing 1 to 4 carbons, benzyl, hydroxyethyl, CH 2 CO 2 H, dimethylaminoethyl R 6 R 7 =lower alkyl containing 1 or 2 carbons, benzyl or R 6 and R 7 together with the nitrogen atom of NR 6 R 7 form the following rings ##STR5## R 8 =lower alkyl containing 1 or 2 carbons, benzyl X.sup.⊖ =halide base=NH 3 , (HOC 2 H 4 ) 3 N, N(CH 3 ) 3 , CH 3 N(C 2 H 4 OH) 2 , NH 2 (CH 2 ) 6 NH 2 , N-methylglucamine, NaOH, KOH.
Claim 3
Dependent Claim 12 words
The method of claim 1 wherein said water soluble derivative is 2'-succinyl-taxol.
Claim 4
Dependent Claim 14 words
The method of claim 1 wherein said water soluble derivative is 2'-succinyl taxol triethanolamine.
Claim 5
Dependent Claim 12 words
The method of claim 1 wherein said water soluble derivative is 2'-glutaryl-taxol.
Claim 6
Dependent Claim 14 words
The method of claim 1 wherein said water soluble derivative is 2'-glutaryl-taxol triethanolamine salt.
Claim 7
Dependent Claim 15 words
The method of claim 1 wherein said water soluble derivative is 2'-O-ester with N-(dimethylaminoethyl) glutamide.
Claim 8
Dependent Claim 17 words
The method of claim 1 wherein said water soluble derivative is 2'-O-ester with N-(dimethylaminoethyl) glutamide hydrochloride salt.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-10-20 1996-04-20 1996-10-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-10-20 2000-04-20 2000-10-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-10-20 2004-04-20 2004-10-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag